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The initial rationale for using adrenal chro-
maffin cells in transplantation experiments was
to provide a paraneural source of dopamine to
replenish the dopamine insufficiency created in
animal models of parkinsonism and idiopathic
Parkinson’s disease. Intraventricular transplants
of adrenal medulla (AM) survive, synthesize and
secrete eatecholamines, and reverse drug-in-
duced motor asymmetries in unilateral nigrostri-
atal lesioned rats. Subsequent studies in which
AM grafts were placed directly into the striatum
also induced functional recovery, albeit partially,
and short-lived. It soon became increasingly
clear that ehromaffin cells survived poorly within
the striatal parenchyma. Studies carried out in
non-human primates and autopsy eases from
AM-grafted parkinsonian patients confirmed the
notion that adrenal ehromaffin cells do not sur-
vive well following intrastriatal transplantation.
The use of trophic factors to improve chro-
maff cell survival heralded the second era of
AM transplantation. Injections of /3. nerve
growth factor into AM graft sites augments
chromaffin cell survival, induces morphological
differentiation, and increases the magnitude and
duration of functional effects. Chromaffin cell
survival can also be increased by cografting AM
with growth factor-producing C6 gliomas, astro-
cytes genetically engineered to produce/3NGF,
and transected peripheral nerve whose damaged
Schwann cells secrete a variety of trophic
molecules including/3NGF.
We have begun to utilize an alternative ap-
proach towards enhancing chromaffin cell sur-
vival. Instead of using trophic molecules to en-
hance graft viability we have attempted to mini-
mize factors which may negatively impact upon
chromaffin cell survival and induce AM grafts to
degenerate. Adrenal chromaffin cells have pre-
viously been demonstrated to survive well fol-
lowing implantation into the periaqueductal gray
once the chromaffin cells were isolated from non-
chromaffin cells found in the AM. These data
suggest that fibroblasts, blood-borne leukocytes,
and/or endothelial cells within the AM may be
detrimental to chromaffin cell viability and, at
least in part, underlie the poor survival of these
cells following intrastriatal implantation.
We presently assessed the effects of isolating
bovine ehromaffin cells from the other cell types
within the AM upon ehromaffin cell graft sur-
vival in rats and MPTP treated rhesus monkeys
following intrastriatal transplantation. Three
groups of immunosuppressed rats were em-
ployed. Group 1 received grafts of bovine AM
following gland perfusion and dissection of the
medulla from the adrenal cortex. Group 2 re-
ceived implants of isolated adrenal chromaffin
cells. Chromaffin cells were isolated in vitro by
placing them in a Pereoll gradient resulting in
the segregation of dead cells, residual cortical
cells, red blood cells, and viable medullary cells.
Once separated, the medullary cells were differ-
entially plated resulting in a 95% pure popula-
tion of chromaffin cells. Group 3 received im-
plants of isolated adrenal chromaffin cells which
were reseeded with fibroblasts and endothelial
cells which were allowed to proliferate in cul-
ture. All rats were sacrificed 1-2 months follow-
ing transplantation. Rats in Group 1 displayed
viable tyrosine hydroxylase (TH) and dopamine
/3 hydroxylase (D/3H)-immunoreactive (ir)
transplants. However, these grafts tended to be
small, the graft-host interface was infiltrated
with macrophages, and many of the chromaffin
cells appeared to be in the process of degenera-
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tion. In contrast, rats receiving implants of iso-
lated chromaffin cells displayed very large and
healthy appearing TH-ir and DflH-ir transplants
which retained their endocrine phenotype. Rats
in this group displayed a 2- and 3-fold increase in
surviving chromaffin cells one and two months
following transplantation, respectively, relative
to rats in Group 1. Isolated chromaffin cell im-
plants appeared to integrate well within the host
and few macrophages were evident. The re-
seeding of isolated chromaffin cells with fibrob-
lasts and endothelial cells impaired chromaffin
cell survival. Most rats in this group failed to dis-
play surviving implants and the few surviving
chromaffin cells appeared to be degenerating.
Interestingly, the perigraft region in rats from
this group displayed a dense TH, but not DflH,
fiber network, suggesting that signals from de-
generating implants may modify the host nigros-
triatal system.
To assess the ability of isolated adrenal chro-
maffi cells to survive grafting in the primate
brain, these cells were implanted into the cau-
date and putamen of immunosuppressed hemi-
parkinsonian rhesus monkeys. One month fol-
lowing transplantation, robust survival
(> 1,000,000) of endocrine appearing TH- and
D/3H-immunoreactive chromaffin cells was ob-
served. These cells appeared to integrate well
within the striatum.
These data strongly suggest that non-chro-
maffi cell constituents within the AM are
detrimental to the survival of chromaffin cells
following intracerebral transplantation. Isolating
chromaffin cells prior to transplantation may
significantly enhance their survival and may be
an improved donor source for the treatment of
Parkinson’s disease.
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